The collaboration will combine Sanofi’s mRNA drug candidates with ScionxBio’s AI-driven TERA platform to develop ...
The DNA inside our cells isn’t just a series of instructions, but something far more dynamic. Like scientists, AI models ...
Researchers redesigned lipid nanoparticles to cut liver accumulation of locally injected mRNA by up to eighty-fold in mice ...
Immunotherapy with checkpoint inhibitors has revolutionized cancer therapy and enabled considerable therapeutic advances for ...
A study in unstressed yeast found that loss of the ribosome-associated chaperone Zuo1 allowed transcripts encoding more disordered proteins to accumulate, supporting a model in which Zuo1 senses the ...
ScionxBio enters worldwide strategic collaboration and licensing pact with Sanofi to develop long-acting xRNA herapeutics: Cambridge, UK Thursday, October 22, 2026, 18:00 Hrs [IST ...
The clinical-scale mRNA manufacturing and R&D facility is one of three strategic pillars of BioNTech's presence in Australia, which is focused on contributing to the local mRNA ecosystem as well as ...
La Trobe University is now home to one of the world's leading biopharmaceutical companies, with the official opening of BioNTech's state-of-the-art ...
The StratNeuro Starting Grant is intended to support outstanding neuroscience researchers at the beginning of their careers, who have received a Vetenskapsrådet (VR) starting grant or a Karolinska ...
Do you ever find yourself struggling when asked about the functions or connections of biology terms, even though you have ...
Presentation will feature new preclinical data of CPTx’s proprietary immune-quiet DNA vector delivered non-virally with targeting lipid ...
Sierk Poetting, Ph.D., Chief Operating Officer at BioNTech said: “Our partnership with the Victorian Government demonstrates how public-private collaboration can build lasting c ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results